Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Antenatal diagnosis and treatment of congenital adrenal hyperplasia
Maria I. New
Research output
:
Contribution to journal
›
Article
›
peer-review
11
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antenatal diagnosis and treatment of congenital adrenal hyperplasia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Congenital Adrenal Hyperplasia
100%
Antenatal Diagnosis
100%
Antenatal Treatment
100%
Prenatal Treatment
66%
21-Hydroxylase Deficiency (21OHD)
66%
Cortisol
66%
At Birth
33%
Cholesterol
33%
Autosomal Recessive
33%
Prenatal Diagnosis
33%
Monogenic
33%
Genital Ambiguity
33%
Steroidogenesis
33%
Genitalia
33%
21-hydroxylase
33%
Adrenal Cortex
33%
Classical Form
33%
Medicine and Dentistry
Congenital Adrenal Hyperplasia
100%
Prenatal Diagnosis
100%
Enzyme Defect
66%
Hydrocortisone
66%
Dexamethasone
33%
Neonatal Infant
33%
Autosomal Recessive Disorder
33%
Ambiguous Genitalia
33%
Steroid 21 Monooxygenase Deficiency
33%
Adrenal Cortex
33%
21-Hydroxylase
33%
Steroidogenesis
33%
Biochemistry, Genetics and Molecular Biology
Enzyme
100%
21-Hydroxylase
100%
Cortisol
100%
Genetics
50%
Autosomal Recessive Disorder
50%
Steroid Biosynthesis
50%
Dexamethasone
50%
Pharmacology, Toxicology and Pharmaceutical Science
Congenital Adrenal Hyperplasia
100%
Enzyme Defect
66%
Hydrocortisone
66%
Dexamethasone
33%
Steroid 21 Monooxygenase Deficiency
33%
Autosomal Recessive Disorder
33%
Ambiguous Genitalia
33%
21-Hydroxylase
33%